Gilead Sciences, Inc.

Investment Portfolio & 13F Holdings Analysis

About

GILEAD SCIENCES, INC. is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 14 holdings worth $1.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-13
Total Holdings: 14
Total Value: 1181331731
Accession Number: 0001123292-25-000217
Form Type: 13F-HR
CIK: 0000882095
Manager Name: Gilead Sciences, Inc.

Data Enrichment

100% identified

14 identified0 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

14 positions • $1,181,331.731K total value

14 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Sort by:

Arcellx, Inc.

ACLX|03940C100

6720803(+0.0%)

Value:

$440.9B(-14.5%)

GALAPAGOS NV

GLPG|36315X101

16707477(+0.0%)

Value:

$419.4B(-9.2%)

Arcus Biosciences, Inc.

RCUS|03969F109

31424760(+4.5%)

Value:

$246.7B(-44.9%)

ASSEMBLY BIOSCIENCES, INC.

ASMB|045396207

2209471(+0.0%)

Value:

$21.1B(-39.4%)

Merus N.V.

MRUS|N5749R100

452527(+0.0%)

Value:

$19.0B(+0.1%)

Kyverna Therapeutics, Inc.

KYTX|501976104

4126119(+0.0%)

Value:

$8.0B(-48.4%)

Tango Therapeutics, Inc.

TNGX|87583X109

4854443(+0.0%)

Value:

$6.7B(-55.7%)

Xilio Therapeutics, Inc.

XLO|98422T100

9105451(+0.0%)

Value:

$6.6B(-24.1%)

Kalaris Therapeutics, Inc.

KLRS|482929106

723273

Value:

$5.8B

HOOKIPA Pharma Inc.

HOOK|43906K209

1875945(+0.0%)

Value:

$2.0B(-46.3%)

Allogene Therapeutics, Inc.

ALLO|019770106

1156689(+0.0%)

Value:

$1.7B(-31.4%)

LEAP THERAPEUTICS, INC.

LPTX|52187K200

5319148(+0.0%)

Value:

$1.6B(-89.4%)

Ikena Oncology, Inc.

IKNA|45175G108

1159145(-42.3%)

Value:

$1.5B(-55.0%)

Barinthus Biotherapeutics plc.

BRNS|91864C107

369855(-40.4%)

Value:

$359.8M(-52.0%)

Instrument	Shares		Other Manager	Value
Arcellx, Inc.(ACLXcusip03940C100)	6.7M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$440.9M	QoQ -14.46% (-$74.5M) YoY-
Galapagos Nv(GLPGcusip36315X101)	16.7M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$419.4M	QoQ -9.16% (-$42.3M) YoY-
Arcus Biosciences, Inc.(RCUScusip03969F109)	31.4M	QoQ +4.53% (-1.4M) YoY-	All Managers (Combined)	$246.7M	QoQ -44.88% (-$200.9M) YoY-
Assembly Biosciences, Inc.(ASMBcusip045396207)	2.2M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$21.1M	QoQ -39.41% (-$13.7M) YoY-
Merus N.V.(MRUScusipN5749R100)	452.5K	QoQ 0.00% (+0) YoY-	All Managers (Combined)	$19.0M	QoQ +0.09% (+$18.1K) YoY-
Kyverna Therapeutics, Inc.(KYTXcusip501976104)	4.1M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$8.0M	QoQ -48.39% (-$7.5M) YoY-
Tango Therapeutics, Inc.(TNGXcusip87583X109)	4.9M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$6.7M	QoQ -55.66% (-$8.3M) YoY-
Xilio Therapeutics, Inc.(XLOcusip98422T100)	9.1M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$6.6M	QoQ -24.14% (-$2.1M) YoY-
Kalaris Therapeutics, Inc.(KLRScusip482929106)	723.3K	QoQ NEW(+723.3K) YoY-	All Managers (Combined)	$5.8M	QoQ NEW(+$5.8M) YoY-
Hookipa Pharma Inc.(HOOKcusip43906K209)	1.9M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$2.0M	QoQ -46.26% (-$1.7M) YoY-
Allogene Therapeutics, Inc.(ALLOcusip019770106)	1.2M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.7M	QoQ -31.45% (-$775.0K) YoY-
Leap Therapeutics, Inc.(LPTXcusip52187K200)	5.3M	QoQ 0.00% (-0) YoY-	All Managers (Combined)	$1.6M	QoQ -89.38% (-$13.7M) YoY-
Ikena Oncology, Inc.(IKNAcusip45175G108)	1.2M	QoQ -42.28% (-849.2K) YoY-	All Managers (Combined)	$1.5M	QoQ -54.95% (-$1.8M) YoY-
Barinthus Biotherapeutics Plc.(BRNScusip91864C107)	369.9K	QoQ -40.37% (-250.5K) YoY-	All Managers (Combined)	$359.8K	QoQ -51.99% (-$389.6K) YoY-